Tag: NIH
-
Therapeutic Food-Triggered Gut Microbes in Development
A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Antibiotic Shown to Control Drug-Resistant Gonorrhea
Findings from a clinical trial show a candidate drug kills bacteria causing a type of gonorrhea becoming resistant to current antibiotics.
-
FDA Holding Opioid Overdose App Competition
The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose.
-
Small Business Grant Funds Flu Therapy R&D
A biotechnology company in South Dakota is developing an influenza therapy, with backing from a National Institutes of Health program supporting research by small enterprises.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Molecular Express, Baylor Medicine Partner on Vaccines
Vaccine developer Molecular Express and Baylor College of Medicine in Houston are developing boosters for vaccines from pieces of viruses that increase immune response to disease, including cancer.
-
NIH Funding Trial of Precise Tumor Removal System
A company making a system to guide surgery that promises more complete removal of breast tumors received funding for a large-scale clinical trial testing the technology.
-
Cocaine Vaccine Trial Recruitment Underway
An early-stage clinical trial testing a vaccine designed to prevent cocaine from reaching the brain started recruiting participants in New York.
-
Common Antibodies Found for Multi-Virus Flu Vaccine
A team at National Institutes of Health discovered three types of antibodies that can neutralize a variety of influenza viral strains infecting humans.